Jazz Pharmaceuticals

New Jazz Pharmaceuticals facility in Monksland officially opened

Jazz Pharmaceuticals

The official opening of a new €50 million Jazz Pharmaceuticals manufacturing and development facility in Monksland took place today.

Jazz Pharmaceuticals is a global pharmaceutical company with its headquarters in Dublin where it employees approximately 100 people. The company expects to employ up to 50 people in Monksland within three years.

Jazz Pharmaceuticals also has operations in multiple cities in the USA, in Oxford, England and in Villa Guardia, Italy. This is the first directly owned, managed and operated manufacturing facility built by Jazz. The work commenced in February 2014 and was supported by IDA Ireland.

The ceremony was performed by Minister for Jobs, Enterprise and Innovation, Ms. Mary Mitchell O’Connor, the Global Head of Life Sciences of IDA Ireland, Mr. Barry Heavey and the Chairman and Chief Executive of Jazz Pharmaceuticals, Bruce Cozadd.

Speaking at the event Bruce Cozadd said

“We were encouraged to come to Roscommon because of the excellent track record of this community in supporting the pharmaceutical industry and the pool of local talent available. We would like to acknowledge the local community, the Roscommon Country Council and IDA Ireland for their continued support and collaboration, and note the remarkable pro-business environment in Ireland that facilitates investments like this one.”

Minister Mary Mitchell O’Connor said, “I’m delighted to be present today to mark the official opening of Jazz Pharmaceuticals’ first manufacturing plant in Ireland. Having a global pharmaceutical company of this calibre establish such a facility in Co. Roscommon is hugely significant, demonstrating serious commitment by the company to the region. The jobs created when the facility is operating at full capacity will be of great benefit to the local area and economy.”